AXL and melanoma: Increase melanocytic differentiation markers, decrease BRN2, AXL, EZH2 and EMT markers, and decrease melanoma cell invasion in vitroAM404+GSK126 (EZH2i) reverse phenotype switchingAM404+GSK126 induce apoptosis and sensitize melanoma cells to MAPKi